These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Consulting Prof. Dr. Stephan Matthaei. Quakenbrück diabetes center. Prescription relevant conclusions]. Matthaei S. MMW Fortschr Med; 2007 Apr 12; 149(15):53. PubMed ID: 17668779 [No Abstract] [Full Text] [Related]
24. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? Standl E, Schnell O. Diabetes Care; 2008 Feb 12; 31 Suppl 2():S136-9. PubMed ID: 18227474 [No Abstract] [Full Text] [Related]
25. [Oral blood glucose-lowering medication as a monotherapy in gestational diabetes: a hotly debated topic]. de Valk HW. Ned Tijdschr Geneeskd; 2009 Feb 12; 153():A330. PubMed ID: 19785815 [Abstract] [Full Text] [Related]
26. [Thus to avoid complications of diabetes. To combine early]. MMW Fortschr Med; 2001 Nov 01; 143(44):60. PubMed ID: 11732409 [No Abstract] [Full Text] [Related]
27. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R, American Heart Association, American Diabetes Association. Circulation; 2003 Dec 09; 108(23):2941-8. PubMed ID: 14662691 [No Abstract] [Full Text] [Related]
28. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy]. González-Ortiz M, Martínez-Abundis E, Grupo para el Tratamiento de la Diabetes Mellitus con Combinaciones. Rev Invest Clin; 2004 Dec 09; 56(3):327-33. PubMed ID: 15612515 [Abstract] [Full Text] [Related]
29. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A. Clin Ther; 2004 Dec 09; 26(12):2066-75. PubMed ID: 15823770 [Abstract] [Full Text] [Related]
30. Insulin initiation in Type 2 diabetes. Page S. Diabet Med; 2005 Sep 09; 22 Suppl 4():2-5. PubMed ID: 16109011 [No Abstract] [Full Text] [Related]
31. A comparative study of the effects of hypoglycemic agents on serum electrolytes in the diabetic patients. Javaid A, Hasan R, Zaib A, Mansoor S. Pak J Pharm Sci; 2007 Jan 09; 20(1):67-71. PubMed ID: 17337432 [Abstract] [Full Text] [Related]
32. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer. Prescrire Int; 2009 Jun 09; 18(101):115. PubMed ID: 19637427 [No Abstract] [Full Text] [Related]
33. What comes after metformin for type 2 diabetes. Med Lett Drugs Ther; 2012 Jul 23; 54(1395):58-9. PubMed ID: 22825689 [No Abstract] [Full Text] [Related]
34. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?]. Mehnert H. Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1086-8. PubMed ID: 2500320 [No Abstract] [Full Text] [Related]
35. Apparent resolution of type 2 diabetes mellitus after initiation of potent antiretroviral therapy in a man from Africa with HIV infection. Koeppe J, Kosmiski L. Clin Infect Dis; 2006 May 15; 42(10):e79-81. PubMed ID: 16619143 [Abstract] [Full Text] [Related]
36. Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus. Bokhari SU, Gopal UM, Duckworth WC. Am J Med Sci; 2003 Feb 15; 325(2):66-9. PubMed ID: 12589230 [Abstract] [Full Text] [Related]
37. Chorea in hyperglycemia. Piccolo I, Sterzi R, Thiella G. Diabetes Care; 1998 Oct 15; 21(10):1777. PubMed ID: 9773750 [No Abstract] [Full Text] [Related]